依达拉奉联合醒脑静治疗急性脑出血的临床疗效

Clinical Observation of Edaravone plus Xingnaojing Injection in the Treatment of Acute cerebral Hemorrhage

目的探讨依达拉奉联合醒脑静治疗急性脑出血的临床疗效。方法选取急性脑出血患者73例,随机将其分为两组,观察组40例患者给予依达拉奉联合醒脑静治疗,对照组33例患者给予醒脑静治疗,比较两组患者的临床疗效。结果观察组患者治疗总有效率为95.0%,明显高于对照组的72.7%,差异有统计学意义(P<0.05);两组患者神经功能缺损评分均较治疗前降低,且观察组降低更明显,差异均有统计学意义(均P<0.05);两组患者治疗过程中均无严重不良反应发生。结论依达拉奉联合醒脑静注射液治疗急性脑出血疗效优于单用醒脑静注射液治疗,两药联合能有效改善患者的神经功能缺损,并提高总体疗效。

Objective To investigate the clinical efficacy of edaravone combined with Xingnaojing Injection in the treatment of acute cerebral hemorrhage.Methods Methods 73 patients with acute cerebral hemorrhage,and randomly divided into two groups,group 40 patients were given edaravone combined with Xingnaojing treatment,the control group of 33 patients treated with Xingnaojing treatment,the clinical efficacy was compared between the two groups.Results The observation group the total effective rate was 95.0%,significantly higher than 72.7% in the control group,the difference was statistically significant（P〈0.05）;decreasing the score of two groups of patients with neurological deficits than before treatment,and the observation group decreased more obviously,the difference was statistically significant（P〈0.05）;the two groups of patients during treatment were no serious adverse reaction. Conclusion Treated with Xingnaojing injection is better than that of single hemorrhage curative effect of edaravone combined with Xingnaojing Injection in the treatment of acute brain,the combination of two drugs can effectively improve neurological function,and improve the overall efficacy.